views of Apollo Hospitals Enterprise LtdQ2FY25 Result by Prathamesh Masdekar, Research Analyst, StoxBox

 – Apollo Hospitals Enterprise Ltd. reported robust performance in Q2FY25, with an increase in EBITDA and PAT margins.

– Consolidated Revenue from Operations stood at Rs. 5,589 crores in Q2FY25, up 15.3% YoY / up 9.9% QoQ. The revenue driven by higher demand for its healthcare service

– EBITDA increased 30.0% YoY / up 20.8% QoQ to Rs. 816 crores, while EBITDA margin stood at 14.6% (up 164bps YoY / up 132bps QoQ) in Q2FY25, led by an expansion in gross margins by 45bps QoQ to 48.9%.

– The Profit after Tax stood at Rs. 396 crores (up 59.0% YoY / up 25.4% QoQ) in Q2FY25, above market expectations of Rs. 367 crores. The PAT margin rose to 7.1% versus 6.2% in Q2FY24.

– The company’s digital health and pharmacy vertical, which offers online consultations and operates the ‘Apollo 24/7′ platform, reported a profit of 389 mn rupees, compared with a loss a year ago, further boosting the hospital chain operator’s margins.

– Apollo Hospitals had 7,994 operating beds across the network (excluding AHLL & managed beds), out of which 2,557 were new. The overall occupancy for hospitals was at 73% vs 68% in the same period in the previous year, aided by a strong increase in patient flows across hospitals.

– Apollo Hospitals announced the expansion of its existing hospital facility in Lucknow to 500 beds from the present 300 beds by adding another 200 beds, to be developed on their recent acquisition of a 1.2-acre land.

– The Government signed an MoU with Apollo Hospitals to provide free treatment for children with heart disease, as announced by the Tripura Chief Minister.

– Apollo Hospitals continues to boost medical tourism, strengthening its global position as a healthcare destination for advanced treatments.